Eli Lilly and Company has announced plans to build a new $6.5 billion manufacturing facility at Generation Park in Houston, ...

Kashiv BioSciences commercially launched Pexegra, a biosimilar referencing Neulasta, and Filra, a biosimilar referencing ...

Drug developers are now frequently tasked with designing oral products for molecules with low solubility and low permeability ...

Step into a leadership role with Contract Pharma, one of the most influential media brands shaping today’s pharmaceutical ...

This year marks a second year of success at the Pharma Industry Awards, with a win in 2024 for Large Pharma Project of the ...

The Conference was a great success, with a sold-out exhibit hall and great line up of speakers and sessions that addressed key industry topics.

Soft Mist Inhalers market expected to grow at a CAGR of 6.8% from 2023 to 2031 and reach more than £4.4 Bn by the end of 2031.

Recent geopolitical developments have highlighted the vulnerabilities of globalized supply chains. The pandemic, tariffs, and ...

Arkivum has partnered with PHARMASEAL, the provider of the Engility Trial Management Platform, which consists of a Clinical ...

RION has engaged Lonza to provide cGMP manufacturing and technical support for commercial-scale production of Rion’s PEP drug ...

Xmoor Pharma and Siam Bioscience have partnered to build a center for Cell and Gene Therapy (CGT) development and ...

Eutecma, a German-based developer of sustainable, modular, and reusable temperature-controlled packaging solutions for ...